Total Payments
$1,374
2024 Payments
$1,088
Companies
18
Transactions
62
Payment Breakdown by Category
Food & Beverage$1,374 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,374 | 62 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $268.20 | 10 | $0 (2024) |
| SK Life Science, Inc. | $186.27 | 10 | $0 (2024) |
| ABBVIE INC. | $169.78 | 11 | $0 (2024) |
| UCB, Inc. | $121.82 | 4 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $119.89 | 5 | $0 (2024) |
| Genentech USA, Inc. | $115.32 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $62.85 | 3 | $0 (2024) |
| Eisai Inc. | $55.75 | 3 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $54.76 | 2 | $0 (2024) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $50.77 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,088 | 51 | Teva Pharmaceuticals USA, Inc. ($199.34) |
| 2023 | $286.32 | 11 | Neurocrine Biosciences, Inc. ($81.50) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: Central Nervous System | ||||||
| 09/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: Central Nervous System | ||||||
| 09/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.14 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $15.92 | General |
| 09/03/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Neurology | ||||||
| 08/26/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: PAIN | ||||||
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 07/30/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Neuroscience | ||||||
| 07/29/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $10.28 | General |
| 07/23/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Neurology | ||||||
| 07/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), EXSERVAN, RADICAVA ORS | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 07/01/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.31 | General |
| 06/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | Genentech USA, Inc. | Enspryng (Biological), Ocrevus | Food and Beverage | In-kind items and services | $33.38 | General |
| Category: Immunology | ||||||
| 06/20/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $12.46 | General |
| 06/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Central Nervous System | ||||||
| 06/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Neurology | ||||||
About Binu Bashyal, APRN, FNP-C
Binu Bashyal, APRN, FNP-C is a Primary Care healthcare provider based in Bedford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2023. The National Provider Identifier (NPI) number assigned to this provider is 1669251617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Binu Bashyal, APRN, FNP-C has received a total of $1,374 in payments from pharmaceutical and medical device companies, with $1,088 received in 2024. These payments were reported across 62 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,374).
Ad
Practice Information
- Specialty Primary Care
- Other Specialties Nurse Practitioner, Pediatrics
- Location Bedford, TX
- Active Since 09/27/2023
- Last Updated 01/21/2025
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1669251617
Products in Payments
- Austedo XR (Drug) $262.19
- Enspryng (Biological) $115.32
- BOTOX (Biological) $65.18
- KESIMPTA (Drug) $62.85
- INGREZZA (Drug) $62.33
- Briviact (Drug) $60.32
- Ongentys (Drug) $57.56
- QULIPTA (Drug) $55.86
- Leqembi (Drug) $55.75
- Xeomin (Biological) $54.76
- RADICAVA (Drug) $50.77
- UBRELVY (Drug) $48.74
- Rystiggo (Drug) $34.50
- EMGALITY (Drug) $27.42
- Fintepla (Drug) $27.00
- PERCEPT PC BRAINSENSE (Device) $26.37
- UPLIZNA (Biological) $22.82
- NEXVIAZYME (Biological) $21.27
- Motpoly XR (Drug) $21.09
- VALTOCO (Drug) $18.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Bedford
Ramsey Keyes, Fnp, FNP
Primary Care — Payments: $1,625
Primary Care $1,625
Annmarie Jones, Np, NP
Primary Care — Payments: $1,511
Primary Care $1,511
Christine Linert, Fnp-C, FNP-C
Primary Care — Payments: $262.39
Primary Care $262.39
Christina Rebic
Primary Care — Payments: $257.65
Primary Care $257.65
Angela Young
Primary Care — Payments: $168.66
Primary Care $168.66
Mrs. Zamar Raza, M.d, M.D
Primary Care — Payments: $13.90
Primary Care $13.90